Abstract
Antibodies are central to immune defenses. Despite advances in understanding the mechanisms of antibody generation, a comprehensive model of how intrinsic and external factors shape human humoral responses to viruses is lacking. Here, we apply PhIP-Seq to investigate the effects of demographic and genetic factors on antibody reactivity to more than 97,000 viral peptides in 1,212 healthy adults. We demonstrate that age, sex, and continent of birth extensively influence the viruses and viral epitopes targeted by the human antibody repertoire. Among 108 lifestyle and health-related variables, smoking exerts the strongest, yet reversible, impact on antibody profiles, primarily against rhinoviruses. Additionally, we identify strong associations between antibodies against 34 viruses and genetic variants at HLA, FUT2, IGH, and IGK genes, some of which increase autoimmune disease risk. These findings offer a valuable resource for understanding the factors affecting antibody-mediated immunity, laying the groundwork for optimizing vaccine strategies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.milieuinterieur.fr/en/
Funding Statement
The study received funding from the Wenner-Gren Foundation and benefited from the support of the French government program Investissement d'Avenir, managed by the Agence Nationale de la Recherche (reference 10-LABX-69-01).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institut Pasteur (Pasteur ID-RCB Number:2012-A00238-35), the Comités de Protection des Personnes, Ouest 6 and Sud Méditerranée (CPP), the Agence Nationale de Sécurité du Médicament (ANSM) and the Commission nationale de l'informatique et des libertés (CNIL) gave ethical approval for the Milieu Intérieur clinical study and this work. The ethics committee of Ghent University (B670201214647), the Ethics Board of Institut Pasteur (EVOIMMUNOPOP-281297), the Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé (CCITRS), the CPP and the CNIL gave ethical approval for the EvoImmunoPop study and this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵13 Deceased
This version has undergone extensive revision with updates to all sections and figures in the paper. The most significant differences include a change of focus to patterns of epitope divergence, the removal of analyses of immune-related data, the addition of WGS data to the GWAS analysis, and a new section analyzing factors explaining the total variance in antibody reactivity patterns. We've also added a supplementary note containing a description of extensive data quality control efforts, a study of how VirScan data can be used to predict viral serostatus, and a more in-depth description of analyses on the relationship between lifestyle and health variables to the antiviral antibody repertoire.
Data Availability
The VirScan3 PhIP-seq raw and processed data generated in this study have been deposited in the Institut Pasteur data repository, OWEY, which can be accessed via the following link: https://dataset.owey.io/doi/10.48802/owey.84rn-jg72?version=1.1. All association statistics obtained in this study can be explored and downloaded from the web browser http://mirepertoire.pasteur.cloud/. The SNP array data can be accessed in the European Genome-Phenome Archive (EGA) with the accession code EGAS00001002460. All Milieu Intérieur datasets can be accessed by submitting a data access request to milieuinterieurdac{at}pasteur.fr, the Milieu Intérieur data access committee (DAC). The DAC informs all the research participants of the data access request and grants data access if the request is consistent with the informed consent signed by the participants. In particular, research on Milieu Intérieur datasets is restricted to research on the genetic and environmental determinants of human variation in immune responses. Data access is typically granted two months after request submission.
